{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:41:54Z","timestamp":1792017714871,"version":"4.4.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019832","name":"Galapagos NV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>We investigated the correlations between patient-reported outcome measures (PROMs) and other measures of inflammatory bowel disease (IBD) activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature review was performed up to June 2022. Searches were conducted in PubMed, Scopus, and Web of Science. A descriptive analysis was performed. The search protocol was registered in PROSPERO (CRD42022383899).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen studies assessed correlations between PROMs and clinical, endoscopic, and laboratory measures of disease activity in IBD. In Crohn\u2019s disease (CD), weak positive correlations were reported for PROMs (eg, the 2 item patient-reported outcome [PRO-2], mobile Health Index [mHI] for CD) and endoscopic scores, more often the Simple Endoscopic Score for CD (SES-CD). In ulcerative colitis (UC), PROMs like PRO-2, the Monitor IBD at Home rectal bleeding item, and the mHI showed weak-to-moderate correlations with the Mayo endoscopic subscore (MES). PROMs also demonstrated limited concordance with laboratory measures such as fecal calprotectin (FCP) and C-reactive protein (CRP) in both CD and UC. The substantial heterogeneity in study designs precluded a structured analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although current PROMs offer valuable complementary insights into IBD control from the patient\u2019s perspective, they cannot replace objective measures of IBD activity. Future research should focus on refining PROMs and generating composite indices to improve their accuracy and usefulness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjaf132","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T11:47:37Z","timestamp":1754567257000},"source":"Crossref","is-referenced-by-count":6,"title":["Patient-reported outcome measures poorly correlate with objective inflammatory bowel disease activity measures: a systematic review"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6278-9663","authenticated-orcid":false,"given":"Xavier","family":"Calvet","sequence":"first","affiliation":[{"name":"Gastroenterology Unit, Parc Taul\u00ed University Hospital, Parc Taul\u00ed Research and Innovation Institute (I3PT-CERCA) , Sabadell,","place":["Spain"]},{"name":"Department of Medicine, Autonomous University of Barcelona , Bellaterra,","place":["Spain"]},{"name":"CIBERehd, Carlos III Health Institute , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-3722","authenticated-orcid":false,"given":"Maria Giovanna","family":"Ferrario","sequence":"additional","affiliation":[{"name":"Medical Statistics Consulting SL , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0738-863X","authenticated-orcid":false,"given":"Vanessa","family":"Marfil","sequence":"additional","affiliation":[{"name":"Medical Statistics Consulting SL , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3613-3665","authenticated-orcid":false,"given":"Santos","family":"Armenteros","sequence":"additional","affiliation":[{"name":"Galapagos Biopharma Spain SL , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5915-1477","authenticated-orcid":false,"given":"Manuel","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Unit, University Clinical Hospital of Santiago de Compostela , Santiago de Compostela,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025102819155038500_jjaf132-B1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"2025102819155038500_jjaf132-B2","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A comprehensive review and update on ulcerative colitis","volume":"65","author":"Gajendran","year":"2019","journal-title":"Dis Mon"},{"key":"2025102819155038500_jjaf132-B3","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"2025102819155038500_jjaf132-B4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12913-020-05383-3","article-title":"Patient feedback to improve quality of patient-centred care in public hospitals: A systematic review of the evidence","volume":"20","author":"Wong","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2025102819155038500_jjaf132-B5","article-title":"Reframing patient experience approaches and methods to achieve patient-centeredness in healthcare: Scoping review","volume":"19","author":"Kim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025102819155038500_jjaf132-B6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40271-019-00407-5","article-title":"A qualitative research for defining meaningful attributes for the treatment of inflammatory bowel disease from the patient perspective","volume":"13","author":"Louis","year":"2020","journal-title":"Patient"},{"key":"2025102819155038500_jjaf132-B7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41395-018-0246-x","article-title":"Refocusing IBD patient management: Personalized, proactive, and patient-centered care","volume":"113","author":"Siegel","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2025102819155038500_jjaf132-B8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5217\/ir.2018.00113","article-title":"Improving the quality of care for inflammatory bowel disease","volume":"17","author":"Ye","year":"2019","journal-title":"Intest Res"},{"key":"2025102819155038500_jjaf132-B9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bmjqs-2020-012565","article-title":"Have we forgotten the moral justification for patient-centred care?","volume":"31","author":"Russell","year":"2022","journal-title":"BMJ Qual Saf"},{"key":"2025102819155038500_jjaf132-B10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pec.2014.08.021","article-title":"Patient-centered interventions to improve medication management and adherence: A qualitative review of research findings","volume":"97","author":"Kuntz","year":"2014","journal-title":"Patient Educ Couns"},{"key":"2025102819155038500_jjaf132-B11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11606-016-3851-7","article-title":"Recommendations for providers on person-centered approaches to assess and improve medication adherence","volume":"32","author":"Bosworth","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2025102819155038500_jjaf132-B12","author":"Bjorner","year":"2006"},{"key":"2025102819155038500_jjaf132-B13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/hex.13254","article-title":"Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues","volume":"24","author":"Churruca","year":"2021","journal-title":"Health Expect"},{"key":"2025102819155038500_jjaf132-B14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1155\/2014\/792386","article-title":"Patient-reported outcome measures in inflammatory bowel disease","volume":"28","author":"El-Matary","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","article-title":"Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: A systematic review","volume":"16","author":"de Jong","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","article-title":"Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus","volume":"12","author":"Kim","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2025102819155038500_jjaf132-B17","doi-asserted-by":"crossref","first-page":"614653","DOI":"10.3389\/fimmu.2021.614653","article-title":"Patient reported outcomes in chronic inflammatory diseases: Current state, limitations and perspectives","volume":"12","author":"Tran","year":"2021","journal-title":"Front Immunol"},{"key":"2025102819155038500_jjaf132-B18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: The SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointestinal Endoscopy"},{"key":"2025102819155038500_jjaf132-B19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn\u2019s disease: A prospective multicentre study. Groupe d\u2018etudes th\u00e9rapeutiques des affections inflammatoires du tube digestif (GETAID)","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"key":"2025102819155038500_jjaf132-B20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"2025102819155038500_jjaf132-B21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","article-title":"Defining disease severity in inflammatory bowel diseases: Current and future directions","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"2025102819155038500_jjaf132-B23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National cooperative Crohn\u2019s disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"2025102819155038500_jjaf132-B24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"2025102819155038500_jjaf132-B25","author":"Programme CAS","year":"2021"},{"key":"2025102819155038500_jjaf132-B26","author":"Armenteros","year":"2022"},{"key":"2025102819155038500_jjaf132-B27","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"2025102819155038500_jjaf132-B28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ecco-jcc\/jjy196","article-title":"Development and validation of a patient-reported score to screen for mucosal inflammation in inflammatory bowel disease","volume":"13","author":"de Jong","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025102819155038500_jjaf132-B29","doi-asserted-by":"crossref","first-page":"2065383","DOI":"10.1155\/2020\/2065383","article-title":"Correlation of patient-reported outcome (PRO-2) with endoscopic and histological features in ulcerative colitis and Crohn\u2019s disease patients","volume":"2020","author":"Dragasevic","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"2025102819155038500_jjaf132-B30","first-page":"304","article-title":"Correlation of stool frequency and abdominal pain measures with simple endoscopic score for Crohn\u2019s disease","volume":"26","author":"Lewis","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025102819155038500_jjaf132-B31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ibd\/izx018","article-title":"Biomarker-based models outperform patient-reported scores in predicting endoscopic inflammatory disease activity","volume":"24","author":"Morris","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2025102819155038500_jjaf132-B32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.cgh.2015.10.035","article-title":"Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies","volume":"14","author":"Van Deen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B33","first-page":"543","article-title":"Development of the Harvey-Bradshaw index-pro (HBI-PRO) score to assess endoscopic disease activity in Crohn\u2019s disease","volume":"11","author":"Zittan","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2025102819155038500_jjaf132-B34","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MCG.0b013e31828b2196","article-title":"Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw Index assessment of Crohn\u2019s disease activity","volume":"47","author":"Bennebroek Evertsz","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"2025102819155038500_jjaf132-B35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.crohns.2012.11.007","article-title":"The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers","volume":"7","author":"Bennebroek Evertsz","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2025102819155038500_jjaf132-B36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic \u00admeasure of disease control from the patient\u2019s perspective: The IBD-control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut"},{"key":"2025102819155038500_jjaf132-B37","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/ajg.2009.197","article-title":"The Manitoba IBD index: Evidence for a new and simple indicator of IBD activity","volume":"104","author":"Clara","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2025102819155038500_jjaf132-B38","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1136\/gutjnl-2016-312307","article-title":"Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"2025102819155038500_jjaf132-B39","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s10620-021-07178-w","article-title":"Patient-reported outcome and clinical scores are equally accurate in predicting mucosal healing in ulcerative colitis: A prospective study","volume":"67","author":"Golovics","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2025102819155038500_jjaf132-B40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5217\/ir.2021.00064","article-title":"Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis","volume":"20","author":"Kamat","year":"2022","journal-title":"Intest Res"},{"key":"2025102819155038500_jjaf132-B41","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.cgh.2019.09.021","article-title":"Discordance between patient-reported outcomes and mucosal inflammation in patients with mild to moderate ulcerative colitis","volume":"18","author":"Ma","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B42","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ibd\/izz038","article-title":"The inflammatory bowel disease symptom inventory: A patient-report scale for research and clinical application","volume":"25","author":"Sexton","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025102819155038500_jjaf132-B43","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1097\/MIB.0000000000000803","article-title":"Validation of a simple 0 to 10 numerical score (IBD-10) of patient-reported inflammatory bowel disease activity for routine clinical use","volume":"22","author":"Subramanian","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2025102819155038500_jjaf132-B44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10620-012-2500-1","article-title":"Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale","volume":"58","author":"Surti","year":"2013","journal-title":"Dig Dis Sci"},{"key":"2025102819155038500_jjaf132-B45","doi-asserted-by":"crossref","first-page":"7618468","DOI":"10.1155\/2019\/7618468","article-title":"Validation of a digital support app to assess inflammatory disease activity and mental health patient-reported outcomes (PROs): A pilot investigation","volume":"2019","author":"Tow","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"2025102819155038500_jjaf132-B46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.gastrohep.2021.08.001","article-title":"Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient\u2019s perspective: IBD-control, EII-control","volume":"45","author":"Vicente Lid\u00f3n","year":"2021","journal-title":"Gastroenterologia y Hepatologia"},{"key":"2025102819155038500_jjaf132-B47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cgh.2017.08.025","article-title":"Heterogeneity in definitions of endpoints for clinical trials of ulcerative colitis: A systematic review for development of a core outcome set","volume":"16","author":"Ma","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cgh.2018.06.015","article-title":"Patient-reported outcomes and endoscopic appearance of ulcerative colitis: A systematic review and meta-analysis","volume":"17","author":"Narula","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102819155038500_jjaf132-B49","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/ajg.2016.580","article-title":"Responsiveness of endoscopic indices of disease activity for Crohn\u2019s disease","volume":"112","author":"Khanna","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2025102819155038500_jjaf132-B50","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1007\/s10620-023-07986-2","article-title":"Correlations between gastrointestinal symptoms and endoscopic-histologic disease activity in adults with ulcerative colitis","volume":"68","author":"Tse","year":"2023","journal-title":"Dig Dis Sci"},{"key":"2025102819155038500_jjaf132-B51","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/apt.17241","article-title":"Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study)","volume":"56","author":"Kulyk","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025102819155038500_jjaf132-B52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.14309\/ajg.0000000000001685","article-title":"Urgency and its association with quality of life and clinical outcomes in patients with ulcerative colitis","volume":"117","author":"Sninsky","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2025102819155038500_jjaf132-B53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.5152\/tjg.2022.21375","article-title":"Usefulness of examining various patient-reported outcomes in predicting endoscopic mucosal healing in ulcerative colitis","volume":"33","author":"Moon","year":"2022","journal-title":"Turk J Gastroenterol"},{"key":"2025102819155038500_jjaf132-B54","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/ecco-jcc\/jjaa057","article-title":"Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: Do we measure what we measure?","volume":"14","author":"van Andel","year":"2020","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Crohn\u2019s and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjaf132\/63983370\/jjaf132.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/9\/jjaf132\/63983370\/jjaf132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/9\/jjaf132\/63983370\/jjaf132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:16:04Z","timestamp":1761693364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjaf132\/8226737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf132","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,8]]},"article-number":"jjaf132"}}